Fig. 3
From: Altered infective competence of the human gut microbiome in COVID-19
Abundance of virulence factors in the microbial community. a Overall abundance (metagenome) of virulence factors encoded by the microbiome of COVID-19 patients and control group. The significance of the differential abundance is indicated with the adjusted p value [adj.p < 0.05; Wilcoxon rank-sum test]. b Overall expression levels (metatranscriptomics) of virulence factors encoded by the microbiome in COVID-19 patients and the control group [adj.p < 0.05; Wilcoxon rank-sum test]. c Abundance and expression levels of MAG families where a significant increase in encoded and expressed virulence factors was observed in COVID-19 patients [adj.p < 0.05; Wilcoxon rank-sum test, * < 0.05, ** < 0.01, *** < 0.001]. d Abundance and expression levels of virulence factors in MAGs depicting taxonomic families only demonstrating an increased expression of virulence factors, with no significant difference observed at a metagenomic level [adj.p < 0.05; Wilcoxon rank-sum test, * < 0.05, ** < 0.01, *** < 0.001]